News Flash

Ethex Corporation Products Recall

January 30, 2009

ETHEX Corporation has expanded two of its previous 2008 recalls. The recall now also includes:

  • More than 60 generic drugs from wholesalers
  • Two generic drugs - Hydromorphone HCl and Metoprolol Succinate - from retailers

These Ethex generic products have been recalled as a precaution because they may have been manufactured under conditions that do not comply with current Good Manufacturing Practices (cGMPs). Some of these drugs have had specific lots recalled previously because of defects found, including oversized tablets potentially leading to twice the level of active ingredient. Therefore, all lots are being recalled to ensure that no other defective products are sold. Generic products manufactured by other companies are not affected by this recall.

Patients who are taking these drugs should continue to take them in accordance with their prescriptions; suddenly stopping necessary medication could put patients at risk. Patients should contact their physician or health care provider if:

  • They have experienced any problems that may be related to taking or using these products.
  • They’d like to order replacement medications or prescriptions.

Read the complete MedWatch 2009 Safety summary, including links to the firm's press release and two previous alerts at http://www.fda.gov/medwatch/safety/2009/safety09.htm#Ethex

Related News: